Non-targeted metabolomics characterization of Annona muricata leaf extracts with anti-angiogenic activity - 13/11/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 10 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
The tropical plant Annona muricata has been widely used for traditional ethnobotanic and pharmacologic applications. Extracts from different parts of this plant have been shown to have a wide range of biological activities. In the present study, we carry out a metabolomic study of both aqueous and DMSO extracts from Annona muricata leaves that has allowed us to identify 33 bioactive compounds. Furthermore, we have shown that aqueous extracts are able to inhibit endothelial cell migration and both aqueous and DMSO extracts inhibit the formation of tubule-like structures by endothelial cells cultured on Matrigel. We conclude that extracts of Annona muricata leaves have great potential as anti-angiogenic natural combinations of bioactive compounds.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Extracts from Annona muricata leaves were characterized by metabolomics. |
• | It was possible to identify 16 bioactive compounds in the aqueous extract. |
• | Other 13 bioactive compounds were identified in the DMSO extract. |
• | Effects of the extracts were tested in several biological assays. |
• | Annona muricata leaves extracts have displayed anti-angiogenetic potential. |
Keywords : Ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC–HRMS), Annona muricata, Graviola, Soursop, Angiogenesis
Plan
Vol 144
Article 112263- décembre 2021 Retour au numéro
Article précédent
- REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
- Shangyi Wang, Mina Kozai, Hironobu Mita, Zimeng Cai, Md. Abdul Masum, Osamu Ichii, Kensuke Takada, Mutsumi Inaba
- The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis
- Xiaohan Wu, He Li, Zhijie Wan, Ran Wang, Jing Liu, Qingfeng Liu, Haiyun Zhao, Zhehuan Wang, Huiru Zhang, Hui Guo, Caihong Qi, Xiangyue Jiao, Xiaotian Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?